Abstract
Anti-CCP antibodies are very specific for the development of RA in patients with very early synovitis.[1] Their predictive value is underscored by their high weighting in an algorithm validated in patients with undifferentiated synovitis
Original language | English |
---|---|
Pages (from-to) | 627-628 |
Number of pages | 2 |
Journal | Annals of the Rheumatic Diseases |
Volume | 69 |
Issue number | 3 |
DOIs | |
Publication status | Published - 20 Oct 2009 |